Ellcef-S 1.5 Injection
Marketer
Ellanjey Lifesciences
Salt Composition
Ceftriaxone (1000mg) + Sulbactam (500mg)
Overview Ellcef-S 1.5 Injection
Cefixime and Sulbactam injection, a dual-action formulation, combats diverse bacterial infections. Its mechanism prevents microbial proliferation and infection spread. Administration must be solely under medical guidance. Adherence to the prescribed schedule is crucial; completing the full course is essential, regardless of symptom improvement. Premature cessation can compromise efficacy. Potential side effects include nausea, vomiting, diarrhea, and dyspepsia. Worsening side effects require immediate medical attention. Allergic reactions (rash, pruritus, edema, dyspnea) necessitate prompt medical help. Prior medication disclosure is vital, especially if you're pregnant, breastfeeding, or using other drugs. Alcohol should be avoided due to potential increased drowsiness. While it usually doesn't affect driving ability, avoid driving if drowsiness or dizziness occurs. Adequate rest, balanced nutrition, and hydration are beneficial for recovery. Monitoring may include lab tests to assess the medicine's effects.
Uses of Ellcef-S 1.5 Injection
Infections caused by bacteria
Major Benefits of Ellcef-S 1.5 Injection:
This medication will be administered by your physician or their designated nurse. Self-medication is strictly prohibited.
Common Side effects of Ellcef-S 1.5 Injection:
- Increased white blood cell count (eosinophils)
- Decreased white blood cell count (lymphocytes)
- Low blood platelets
- Rash
- Diarrhea
- Increased liver enzymes
- Injection site reactions (pain, swelling, redness)
How to use Ellcef-S 1.5 Injection:
This medication will be administered by your physician or their qualified assistant; self-medication is strongly discouraged.
How Ellcef-S 1.5 Injection works:
Ceftriaxone and Sulbactam, combined as Ellcef-S 1.5 Injection, offer a dual-action antibacterial approach. Ceftriaxone, a cephalosporin antibiotic, disrupts bacterial cell wall synthesis, hindering their ability to multiply. Sulbactam, a beta-lactamase inhibitor, counteracts bacterial resistance mechanisms, thereby bolstering Ceftriaxone's effectiveness.
SAFETY ADVICE
AlcoholSAFE
There are no known adverse interactions between Ellcef-S 1.5 Injection and alcohol consumption.
PregnancySAFE IF PRESCRIBED
The injectable medication Ellcef-S 1.5 is typically deemed safe for use in pregnancy. Preclinical trials using animals revealed minimal or no negative consequences for fetal development; the data from human trials, however, remains scarce.
Breast feedingCAUTION
The administration of Ellcef-S 1.5 Injection to breastfeeding mothers requires careful consideration. Lactation should be temporarily discontinued throughout the mother's course of treatment and until the medication is fully cleared from her system.
DrivingUNSAFE
Administering Ellcef-S 1.5 Injection can lead to drowsiness, blurred vision, and dizziness. Driving should be avoided if these effects are experienced.
KidneyCONSULT YOUR DOCTOR
Insufficient data exists regarding the administration of Ellcef-S 1.5 Injection to individuals with renal impairment. Physician consultation is recommended.
LiverCAUTION
The administration of Ellcef-S 1.5 Injection requires careful consideration in individuals with significant hepatic impairment; dosage modification may be necessary. A physician's consultation is advised. Dosage alteration for Ellcef-S 1.5 Injection is not suggested for patients experiencing mild or moderate liver dysfunction.
What if you forget to take Ellcef-S 1.5 Injection :
Omitting a scheduled dose of Ellcef-S 1.5 Injection warrants immediate physician consultation.
Facts to Know About Ellcef-S 1.5 Injection
| Label | Value |
|---|---|
| Developing Habits | No. |
| Treatment Category | Antimicrobials |

